MVA Investors, LLC — SEC Form 4 filings
SEC reporting owner CIK 1468223. 5 Form 4 filings on record with FilingPulse; latest filed 2024-07-02.
Transaction summary — filings shown
Covers all 5 filings on record, filed 2024-01-25 to 2024-07-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 8 legs across 3 filings — 584,731 shares, $4,622,044 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 10.
- Largest priced transaction: sale of 110,731 shares @ $8.87 ($982,184) in Tango Therapeutics, Inc., filed 2024-07-02.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Tango Therapeutics, Inc. (TNGX) | — | 3 | — | 8 legs · 584,731 sh · $4,622,044 | — |
| Mirati Therapeutics, Inc. (MRTX) | — | 1 | — | — | 8 |
| Tyra Biosciences, Inc. (TYRA) | — | 1 | — | — | 2 |
Form 4 filings — MVA Investors, LLC
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2024-07-02 | 4 | Tango Therapeutics, Inc. (TNGX) jointly with Davis Aaron I. | Sale (S): 29,000 @ $8.57 · Sale (S): 110,731 @ $8.87 · Sale (S): 95,000 @ $8.68 | EDGAR |
| 2024-06-07 | 4 | Tango Therapeutics, Inc. (TNGX) jointly with Davis Aaron I. | Sale (S): 63,000 @ $7.24 · Sale (S): 77,000 @ $6.88 | EDGAR |
| 2024-05-03 | 4 | Tango Therapeutics, Inc. (TNGX) jointly with Davis Aaron I. | Sale (S): 75,000 @ $7.43 · Sale (S): 75,000 @ $7.56 · Sale (S): 60,000 @ $7.61 | EDGAR |
| 2024-02-08 | 4 | Tyra Biosciences, Inc. (TYRA) jointly with Boxer Capital, LLC, Boxer Asset Management Inc., LEWIS JOSEPH, Davis Aaron I. | Grant/award (A): 63,412 @ $13.01 · Grant/award (A): 705,280 (derivative) @ $13.01 | EDGAR |
| 2024-01-25 | 4 | Mirati Therapeutics, Inc. (MRTX) jointly with Boxer Capital, LLC, Boxer Asset Management Inc., LEWIS JOSEPH, Davis Aaron I., Dissanayake Shehan Bharatha, Fuglesang Christopher, Braslyn Ltd., Lockend Five, LLC | Disposition to issuer (D): 287,866 · Disposition to issuer (D): 3,201,440 · Disposition to issuer (D): 203,754 · Disposition to issuer (D): 3,135,966 · Disposition to issuer (D): 30,518 · Disposition to issuer (D): 332,809 (derivative) · +2 more | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1468223 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →